ASE Test Inc, a 10% owner of Ainos Inc (AIMD), reported a significant insider transaction on June 23, 2025. The company acquired 29,476 shares of common stock through a Share Exchange Agreement with Taiwan Carbon Nano Technology Corporation.
Key transaction details:
- Acquired shares in exchange for 5,687,109 ordinary shares of Ainos Inc. (Cayman Islands)
- Exchange value approximately $0.497 per share
- Total beneficial ownership following transaction: 58,887 shares
- Ownership form: Direct through ASE Test, indirect through ASE Technology Holding Co., Ltd
This Form 4 filing indicates a strategic share exchange transaction that increases ASE Test's stake in Ainos Inc. The transaction was executed through a formal agreement dated June 3, 2025, demonstrating continued institutional investment interest in the company.
Ainos announced a strategic partnership with Kenmec Mechanical Engineering through an 8-K filing dated June 24, 2025. The company, listed on the Nasdaq Stock Market under symbols AIMD (common stock) and AIMDW (warrants), made this material disclosure in accordance with SEC regulations.
Key details from the filing:
- The partnership agreement is legally binding, though specific terms were not disclosed in the 8-K
- The announcement was made via press release, included as Exhibit 99.1
- The filing was signed by CEO Chun-Hsien Tsai
- Company headquarters: 8880 Rio San Diego Drive, San Diego, CA
This strategic alliance could represent a significant business development for Ainos, potentially impacting its operational capabilities and market position, though investors should refer to the full press release for detailed partnership terms and implications.
Director Chun-Jung Tsai of Ainos reported multiple sales of common stock in June 2025:
- June 18: Sold 5,000 shares at $0.5217 per share
- June 19: Sold 10,903 shares at $0.5517 per share
- June 23: Sold 10,000 shares at $0.50 per share
Following these transactions, Tsai directly owns 1,401,997 shares of common stock, representing a reduction of 25,903 shares from their previous position. The sales occurred at prices ranging from $0.50 to $0.5517 per share, with a total value of approximately $13,900. These insider sales may indicate the director's personal portfolio management decisions or views on the company's valuation.